Parker Melissa M, Moffet Howard H, Adams Alyce, Karter Andrew J
Kaiser Permanente, Division of Research, Oakland, California, USA
Kaiser Permanente, Division of Research, Oakland, California, USA.
J Am Med Inform Assoc. 2015 Sep;22(5):957-61. doi: 10.1093/jamia/ocv054. Epub 2015 Jun 15.
Identifying patients who are medication nonpersistent (fail to refill in a timely manner) is important for healthcare operations and research. However, consistent methods to detect nonpersistence using electronic pharmacy records are presently lacking. We developed and validated a nonpersistence algorithm for chronically used medications.
Refill patterns of adult diabetes patients (n = 14,349) prescribed cardiometabolic therapies were studied. We evaluated various grace periods (30-300 days) to identify medication nonpersistence, which is defined as a gap between refills that exceeds a threshold equal to the last days' supply dispensed plus a grace period plus days of stockpiled medication. Since data on medication stockpiles are typically unavailable for ongoing users, we compared nonpersistence to rates calculated using algorithms that ignored stockpiles.
When using grace periods equal to or greater than the number of days' supply dispensed (i.e., at least 100 days), this novel algorithm for medication nonpersistence gave consistent results whether or not it accounted for days of stockpiled medication. The agreement (Kappa coefficients) between nonpersistence rates using algorithms with versus without stockpiling improved with longer grace periods and ranged from 0.63 (for 30 days) to 0.98 (for a 300-day grace period).
Our method has utility for health care operations and research in prevalent (ongoing) and new user cohorts. The algorithm detects a subset of patients with inadequate medication-taking behavior not identified as primary nonadherent or secondary nonadherent. Healthcare systems can most comprehensively identify patients with short- or long-term medication underutilization by identifying primary nonadherence, secondary nonadherence, and nonpersistence.
识别药物治疗不持续(未能及时重新配药)的患者对于医疗保健运营和研究很重要。然而,目前缺乏使用电子药房记录检测治疗不持续的一致方法。我们开发并验证了一种针对长期使用药物的治疗不持续算法。
研究了开具心脏代谢疗法的成年糖尿病患者(n = 14349)的重新配药模式。我们评估了各种宽限期(30 - 300天)以识别药物治疗不持续,其定义为重新配药之间的间隔超过一个阈值,该阈值等于上次配药的供应天数加上宽限期再加上储存药物的天数。由于正在使用药物的患者的药物储存数据通常不可用,我们将治疗不持续率与使用忽略储存量的算法计算出的比率进行了比较。
当使用等于或大于配药供应天数(即至少100天)的宽限期时,无论是否考虑储存药物的天数,这种新的药物治疗不持续算法都能给出一致的结果。使用有储存量算法和无储存量算法得出的治疗不持续率之间的一致性(卡帕系数)随着宽限期延长而提高,范围从0.63(30天宽限期)到0.98(300天宽限期)。
我们的方法对普遍存在(正在使用)和新用户群体的医疗保健运营和研究有用。该算法检测出一部分服药行为不当的患者,这些患者未被识别为原发性不依从或继发性不依从。医疗保健系统可以通过识别原发性不依从、继发性不依从和治疗不持续,最全面地识别短期或长期药物利用不足的患者。